Cagrisema (10mg + 10mg)

  Product Detail  

I. Core Properties & Formulation

• Component Traits: Cagrilintide mimics the biological activity of amylin, a naturally occurring peptide that modulates satiety signals and postprandial glucose response. Semaglutide acts on GLP-1 receptors to regulate appetite pathways and gastric emptying rate. The dual-component blend enables synergistic research on metabolic and endocrine signaling cascades.
• Physical & Chemical Specifications: Research-grade Cagrisema (10mg+10mg) has a purity of ≥98% (verified by HPLC and mass spectrometry). It is water-soluble after reconstitution, with stable chemical properties under recommended storage conditions.
• Storage & Handling: Unreconstituted lyophilized powder should be stored at -20°C in a desiccated, light-protected container to prevent degradation. After reconstitution with sterile solvent, the solution must be stored at 2–8°C and used within 48 hours. Repeated freeze-thaw cycles are strictly prohibited.

II. Mechanism for Research Applications

1. Dual-Pathway Signaling: Semaglutide binds to GLP-1 receptors to modulate central appetite signals and slow gastric emptying. Cagrilintide activates amylin receptors to enhance satiety and stabilize postprandial glucose fluctuations. Their synergistic interaction is used to investigate dual-agonist effects on metabolic balance.
2. Metabolic Regulation Studies: It serves as a tool to explore the interplay between GLP-1 and amylin pathways in glucose response, energy intake control, and metabolic homeostasis. Researchers use it to observe how dual-peptide stimulation affects biochemical markers in cellular and preclinical models.

III. Key Research Applications

• Metabolic & Endocrine Research: Applied in studies on metabolic signaling pathways, receptor interaction, and the role of dual peptides in energy balance regulation. Suitable for biochemical and cellular experiments investigating glucose response and appetite-related pathways.
• Peptide Formulation Studies: Used to evaluate the stability, compatibility, and bioavailability of fixed-dose peptide combinations, providing data for the development of research-grade peptide blends.
• Preclinical Experimental Models: Employed in controlled laboratory settings to test dual-agonist effects, supporting research on metabolic disorders and related signaling mechanisms.

IV. Safety & Compliance Guidelines

1. For laboratory research use only. Not for human consumption, therapeutic purposes, or veterinary applications.
2. Handle with standard laboratory protective equipment (gloves, lab coat, safety goggles) to avoid direct contact with skin, mucous membranes, or eyes.
3. In case of accidental exposure, rinse the affected area thoroughly with water. Seek medical advice if irritation persists.
4. Dispose of unused peptide, reconstituted solution, and waste materials in accordance with local chemical waste regulations for laboratory reagents.

 About Us